Democrats dramatically narrow their ambitions for lowering insulin costs
WASHINGTON — Democrats’ high hopes to lower insulin costs for patients with insurance got downsized on Sunday, and now only Medicare patients will see relief at the pharmacy counter.
Back in November, the party had grand ambitions of capping insulin costs at $35 per month for all patients with insurance. But when they tried to insert the policy into the sweeping climate, tax, and health care package they’re advancing this month, it conflicted with Senate rules. Now, the plan only caps out-of-pocket costs for Medicare patients who use insulin, around a quarter of whom pay more than $35 per month right now.
Read Original Article: Democrats dramatically narrow their ambitions for lowering insulin costs »
